Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
The Journal of Clinical Psychiatry|May 1, 1985
Polydipsia and chronic hyponatremia in schizophrenic inpatientsD G Kirch, L B Bigelow, D R Weinberger, et al.Neuroscience Letters|August 5, 1991
Chronic haloperidol treatment attenuates receptor-mediated phosphoinositide turnover in rat brain slicesR Li, L L Wing, Y Shen, et al.Schizophrenia Research|May 24, 1997
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteersM H Rapaport, C G McAllister, D Pickar, et al.Archives of General Psychiatry|January 1, 1992
Search for cytomegalovirus in the postmortem brains of schizophrenic patients using the polymerase chain reactionR C Alexander, S A Spector, M Casanova, et al.Acta Psychiatrica Scandinavica|November 1, 1992
Search for evidence of herpes simplex virus, type 1, or varicella-zoster virus infection in postmortem brain tissue from schizophrenic patientsR C Alexander, G Cabirac, T Lowenkopf, et al.Neuropharmacology|June 1, 1990
Effect of chronic caffeine administration on monoamine and monoamine metabolite concentrations in rat brainD G Kirch, T R Taylor, G A Gerhardt, et al.Schizophrenia Bulletin|January 1, 1988
Serum haloperidol concentration and clinical response in schizophreniaD G Kirch, L B Bigelow, E R Korpi, et al.Pharmacology, Biochemistry, and Behavior|July 1, 1991
A clinical trial of nifedipine in schizophrenia and tardive dyskinesiaR L Suddath, G M Straw, W J Freed, et al.Schizophrenia Research|February 1, 1994
Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophreniaM F Egan, C C Duncan, R L Suddath, et al.Journal of Clinical Psychopharmacology|April 1, 1993
The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokineticsV Khot, C L DeVane, E R Korpi, et al.Pageof 6